Cite

HARVARD Citation

    Mousele, C. et al. (2022). 077  Long-term safety and efficacy of mexiletine for patients with myotonic dystrophy type 1 and 2. Journal of neurology, neurosurgery and psychiatry. 93 (6), p. A36. [Online]. 
  
Back to record